We are very encouraged by the impressive weight loss with dapiglutide after 28 weeks, which appears to be on par with the most effective weekly GLP-1 treatments on the market today despite the predominantly male and relatively thin participants, says David Kendall, medical director at Zealand Pharma, in the release
Combination safety profile No documented adverse interactions between BPC-157 and TB-500 emerge from available research or community experience
It also found patients taking the highest dose of the oral GLP-1 agonist, which is currently in development for type 2 diabetes and weight management treatment, lost an average of 7.6% of their body weight
They are not for cosmetic weight loss
BPC 157: Kies het juiste flesje Elk peptide, inclusief BPC 157 moet binnen 4 weken (idealiter) en niet langer dan 6 weken worden gebruikt, omdat de werkzaamheid na deze periode niet meer kan worden gegarandeerd